Literature DB >> 33219921

Urine steroid profile as a new promising tool for the evaluation of adrenal tumors. Literature review.

Marta Araujo-Castro1,2, Pablo Valderrábano3,4, Héctor F Escobar-Morreale3,4,5,6, Felicia A Hanzu7, Gregori Casals8.   

Abstract

PURPOSE: To review the literature assessing the diagnostic performance of urinary steroid profiling (USP) by high-performance liquid chromatography (LC-MS) or gas chromatography (GC) coupled to mass spectrometry (MS) in the evaluation of adrenal lesions, both in terms of functionality and malignancy.
RESULTS: The evaluation of adrenal incidentalomas (AI) aims to rule out malignancy and hormone excess. Current diagnostic protocols have several limitations and include time consuming and relatively complicated multi-step processes in most cases. On the contrary, USP by LC-MS/MS or LC-GC/MS offer an easy, comprehensive and non-invasive assessment of adrenal steroid secretion. USP complements current workups used in the evaluation of AIs by improving our ability to identify malignancy and/or autonomous hormone secretion.
CONCLUSIONS: Urine steroid profiling by LC-MS/MS and GC-MS allows a thorough, non-invasive, assessment of adrenal steroidogenesis as a whole which complement the current evaluation of AIs, and holds a promising role in the diagnosis of autonomous cortisol secretion, primary aldosteronism, and adrenal malignancy.

Entities:  

Keywords:  Adrenal incidentalomas; Autonomous cortisol secretion; Mass spectrometry; Tetra-hydrocortisol; Tetrahydro-11-deoxycortisol; Urine steroid profile

Year:  2020        PMID: 33219921     DOI: 10.1007/s12020-020-02544-6

Source DB:  PubMed          Journal:  Endocrine        ISSN: 1355-008X            Impact factor:   3.633


  48 in total

Review 1.  Autonomous cortisol secretion in adrenal incidentalomas.

Authors:  Marta Araujo-Castro; Miguel Antonio Sampedro Núñez; Mónica Marazuela
Journal:  Endocrine       Date:  2019-03-07       Impact factor: 3.633

2.  Practical guide on the initial evaluation, follow-up, and treatment of adrenal incidentalomas Adrenal Diseases Group of the Spanish Society of Endocrinology and Nutrition.

Authors:  Marta Araujo-Castro; Marta Iturregui Guevara; María Calatayud Gutiérrez; Paola Parra Ramírez; Paola Gracia Gimeno; Felicia Alexandra Hanzu; Cristina Lamas Oliveira
Journal:  Endocrinol Diabetes Nutr (Engl Ed)       Date:  2020-04-26       Impact factor: 1.417

Review 3.  Clinical review: Diagnosis and treatment of subclinical hypercortisolism.

Authors:  Iacopo Chiodini
Journal:  J Clin Endocrinol Metab       Date:  2011-03-02       Impact factor: 5.958

Review 4.  Incidentaloma: from general practice to specific endocrine frame.

Authors:  Ancuta Augustina Gheorghisan-Galateanu; Mara Carsote; Ana Valea
Journal:  J Pak Med Assoc       Date:  2017-06       Impact factor: 0.781

5.  Commentary on the Endocrine Society Practice Guidelines: Consequences of adjustment of antihypertensive medication in screening of primary aldosteronism.

Authors:  Evelyn Fischer; Felix Beuschlein; Martin Bidlingmaier; Martin Reincke
Journal:  Rev Endocr Metab Disord       Date:  2011-03       Impact factor: 6.514

6.  Management of the clinically inapparent adrenal mass ("incidentaloma").

Authors:  Melvin M Grumbach; Beverly M K Biller; Glenn D Braunstein; Karen K Campbell; J Aidan Carney; Paul A Godley; Emily L Harris; Joseph K T Lee; Yolanda C Oertel; Mitchell C Posner; Janet A Schlechte; H Samuel Wieand
Journal:  Ann Intern Med       Date:  2003-03-04       Impact factor: 25.391

7.  Clinical utility of noncontrast computed tomography attenuation value (hounsfield units) to differentiate adrenal adenomas/hyperplasias from nonadenomas: Cleveland Clinic experience.

Authors:  Amir H Hamrahian; Adriana G Ioachimescu; Erick M Remer; Gaspar Motta-Ramirez; Hari Bogabathina; Howard S Levin; Sethu Reddy; Inderbir S Gill; Allan Siperstein; Emmanuel L Bravo
Journal:  J Clin Endocrinol Metab       Date:  2004-11-30       Impact factor: 5.958

8.  The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.

Authors:  John W Funder; Robert M Carey; Franco Mantero; M Hassan Murad; Martin Reincke; Hirotaka Shibata; Michael Stowasser; William F Young
Journal:  J Clin Endocrinol Metab       Date:  2016-03-02       Impact factor: 5.958

9.  Recommended evaluation of adrenal incidentalomas is costly, has high false-positive rates and confers a risk of fatal cancer that is similar to the risk of the adrenal lesion becoming malignant; time for a rethink?

Authors:  T J Cawood; P J Hunt; D O'Shea; D Cole; S Soule
Journal:  Eur J Endocrinol       Date:  2009-05-13       Impact factor: 6.664

10.  Management of adrenal incidentalomas: European Society of Endocrinology Clinical Practice Guideline in collaboration with the European Network for the Study of Adrenal Tumors.

Authors:  Martin Fassnacht; Wiebke Arlt; Irina Bancos; Henning Dralle; John Newell-Price; Anju Sahdev; Antoine Tabarin; Massimo Terzolo; Stylianos Tsagarakis; Olaf M Dekkers
Journal:  Eur J Endocrinol       Date:  2016-08       Impact factor: 6.664

View more
  6 in total

1.  Adrenal venous sampling in primary aldosteronism: Experience of a Spanish multicentric study (Results from the SPAIN-ALDO Register).

Authors:  Marta Araujo-Castro; Miguel Paja Fano; Marga González Boillos; Begoña Pla Peris; Eider Pascual-Corrales; Ana María García Cano; Paola Parra Ramírez; Patricia Martín Rojas-Marcos; Jorge Gabriel Ruiz-Sanchez; Almudena Vicente Delgado; Emilia Gómez Hoyos; Rui Ferreira; Iñigo García Sanz; Mònica Recasens Sala; Rebeca Barahona San Millan; María José Picón César; Patricia Díaz Guardiola; Juan Jesús García González; Carolina M Perdomo; Laura Manjón Miguélez; Rogelio García Centeno; Juan Carlos Percovich; Ángel Rebollo Román; Paola Gracia Gimeno; Cristina Robles Lázaro; Manuel Morales-Ruiz; Felicia A Hanzu
Journal:  Endocrine       Date:  2022-06-25       Impact factor: 3.925

2.  Adrenalectomy improves blood pressure control in nonfunctioning adrenal incidentalomas and glycemic and lipid control in patients with autonomous cortisol secretion.

Authors:  Marta Araujo-Castro; César Mínguez Ojeda; María Noelia Sánchez Ramírez; Victoria Gómez Dos Santos; Eider Pascual-Corrrales; María Fernández-Argüeso
Journal:  Endocrine       Date:  2022-06-25       Impact factor: 3.925

3.  Diagnostic accuracy of the different hormonal tests used for the diagnosis of autonomous cortisol secretion.

Authors:  Marta Araujo-Castro; Ana García Cano; Lucía Jiménez Mendiguchía; Héctor F Escobar-Morreale; Pablo Valderrábano
Journal:  Sci Rep       Date:  2021-10-15       Impact factor: 4.379

4.  Predictors of Tumour Growth and Autonomous Cortisol Secretion Development during Follow-Up in Non-Functioning Adrenal Incidentalomas.

Authors:  Marta Araujo-Castro; Paola Parra Ramírez; Cristina Robles Lázaro; Rogelio García Centeno; Paola Gracia Gimeno; Mariana Tomé Fernández-Ladreda; Miguel Antonio Sampedro Núñez; Mónica Marazuela; Héctor F Escobar-Morreale; Pablo Valderrabano
Journal:  J Clin Med       Date:  2021-11-25       Impact factor: 4.241

Review 5.  Future Directions in Diagnosis, Prognosis and Disease Monitoring of Adrenocortical Carcinoma: Novel Non-Invasive Biomarkers.

Authors:  Yuling Cheng; Wei Kou; Dandan Zhu; Xinbo Yu; Yu Zhu
Journal:  Front Endocrinol (Lausanne)       Date:  2022-02-01       Impact factor: 5.555

6.  Quantification of cortisol and its metabolites in human urine by LC-MSn: applications in clinical diagnosis and anti-doping control.

Authors:  Francesco Arioli; Maria Cristina Gamberini; Radmila Pavlovic; Federica Di Cesare; Susanna Draghi; Giulia Bussei; Francesca Mungiguerra; Alessio Casati; Marco Fidani
Journal:  Anal Bioanal Chem       Date:  2022-08-02       Impact factor: 4.478

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.